Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Carole Diane Mitnick, Sc.D.

Concepts (300)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tuberculosis, Multidrug-Resistant115202594115.990 Why?
Antitubercular Agents1132025138011.660 Why?
Tuberculosis, Pulmonary2720248364.410 Why?
Tuberculosis30202420113.830 Why?
Rifampin1920253503.690 Why?
Mycobacterium tuberculosis54202419113.680 Why?
Nitroimidazoles1120241182.190 Why?
Sputum2320245141.930 Why?
Extensively Drug-Resistant Tuberculosis72023851.700 Why?
Oxazoles1120241981.520 Why?
Peru3220238881.260 Why?
Pyrazinamide52024601.250 Why?
Drug Resistance, Multiple, Bacterial1520175921.230 Why?
Fluoroquinolones1320233071.200 Why?
Microbial Sensitivity Tests23202419721.150 Why?
Directly Observed Therapy920161390.940 Why?
World Health Organization13202413270.850 Why?
Clinical Protocols8202414370.840 Why?
Ofloxacin32017660.610 Why?
Antibiotics, Antitubercular220181000.610 Why?
Deafness120224600.600 Why?
Social Stigma120247880.590 Why?
Clofazimine52024390.590 Why?
Family Characteristics6202210020.580 Why?
International Cooperation4202014340.580 Why?
Molecular Typing120171150.560 Why?
Bacteriological Techniques320132770.560 Why?
Drug Resistance, Bacterial4201710650.550 Why?
Pharmaceutical Preparations2202110860.520 Why?
Cost of Illness4201719490.490 Why?
Humans15920257667660.480 Why?
Hearing Loss120227850.480 Why?
Hepatitis C2202215950.470 Why?
Qualitative Research3202431380.470 Why?
Treatment Outcome492025652730.450 Why?
Community Health Services220136590.440 Why?
Needles120164620.430 Why?
Contact Tracing320192740.420 Why?
Eligibility Determination120164210.410 Why?
Drug Therapy, Combination14202463070.350 Why?
Research Design6201962070.350 Why?
Randomized Controlled Trials as Topic62023103840.310 Why?
Bacterial Proteins1202138330.280 Why?
Adult5120242233070.280 Why?
Salvage Therapy1201312740.270 Why?
Program Development1201312970.270 Why?
Cataract Extraction120104640.260 Why?
Practice Guidelines as Topic3202474310.260 Why?
Clinical Trials, Phase III as Topic320238780.260 Why?
Cohort Studies192022417100.260 Why?
Bayes Theorem4202123540.250 Why?
Prevalence102022158350.250 Why?
Treatment Refusal120084330.240 Why?
Male5520253641420.240 Why?
HIV Infections52024175360.230 Why?
Female5820253965200.230 Why?
Treatment Failure8201826590.230 Why?
Cleft Palate220205960.230 Why?
Patient Care120096290.210 Why?
Administration, Oral4202440180.210 Why?
Retrospective Studies292022816350.210 Why?
Developing Countries8202429130.200 Why?
Drug Administration Schedule8201948530.200 Why?
Young Adult212024599390.190 Why?
Population Surveillance2201125940.180 Why?
Isoniazid320232790.180 Why?
Anti-Inflammatory Agents, Non-Steroidal1201022700.180 Why?
Drug Approval420228200.180 Why?
Compassionate Use Trials22018500.180 Why?
Brazil1202412490.180 Why?
Speech Therapy12020580.170 Why?
Prospective Studies132024548710.170 Why?
Kanamycin32018630.160 Why?
South Africa3202218750.160 Why?
Medical Assistance120201080.160 Why?
Quality Improvement2202038500.160 Why?
Health Care Costs1201232420.160 Why?
Anti-Bacterial Agents3201674750.160 Why?
Speech Disorders120201780.160 Why?
Velopharyngeal Insufficiency120201030.150 Why?
Lesotho32024760.150 Why?
Capreomycin22018140.150 Why?
Financing, Organized120192020.150 Why?
Therapeutic Equivalency120181350.150 Why?
Socioeconomic Factors5202378410.150 Why?
Environmental Exposure1201345540.140 Why?
Adolescent212025889040.140 Why?
Resource Allocation120203540.140 Why?
Middle Aged2820242232570.140 Why?
Interviews as Topic1202427410.140 Why?
Clinical Trials as Topic7202380450.140 Why?
Proportional Hazards Models52020125340.140 Why?
Endpoint Determination220165920.140 Why?
Ethambutol12016590.140 Why?
Government Programs220102780.130 Why?
Drug Monitoring320119620.130 Why?
Hypersensitivity, Immediate120193480.130 Why?
Drugs, Investigational120182110.130 Why?
Child132025806680.130 Why?
Amidohydrolases120161600.130 Why?
Activities of Daily Living1202424290.120 Why?
Emigration and Immigration119984050.120 Why?
DNA Gyrase12016860.120 Why?
Hepacivirus1202213430.120 Why?
Multicenter Studies as Topic2201917330.120 Why?
Evidence-Based Medicine2201636920.120 Why?
Trust120195320.120 Why?
Lung Diseases1202419410.120 Why?
Human Rights119973120.110 Why?
Dose-Response Relationship, Drug52017107450.110 Why?
Professional-Patient Relations120197240.110 Why?
Time Factors92020401490.110 Why?
Genes, Bacterial1201710760.110 Why?
Clinical Trials, Phase II as Topic120166380.110 Why?
Health Personnel2202433840.110 Why?
Amoxicillin-Potassium Clavulanate Combination12013320.110 Why?
California1201714350.110 Why?
Bronchiectasis120151410.110 Why?
Sample Size120168440.110 Why?
Poverty3202227140.110 Why?
Clarithromycin12013870.110 Why?
Ambulatory Care4201127790.110 Why?
Aged1620211713430.100 Why?
Drug Combinations1201820850.100 Why?
Electrolytes220222790.100 Why?
Aza Compounds12011340.090 Why?
Reproducibility of Results32020201440.090 Why?
Philippines42012950.090 Why?
Social Support2201321910.090 Why?
Russia420143830.090 Why?
Long QT Syndrome120154730.090 Why?
Drug Repositioning220242460.090 Why?
Pulmonary Disease, Chronic Obstructive2201532460.090 Why?
Kaplan-Meier Estimate2201965120.080 Why?
Health Expenditures1202223900.080 Why?
Follow-Up Studies62024393090.080 Why?
Rifamycins12009270.080 Why?
Refugees119976150.080 Why?
Pneumonectomy1201611470.080 Why?
Family Health1201312540.080 Why?
Drug Design1201310420.080 Why?
Child, Preschool82025425770.080 Why?
Propensity Score1201619720.070 Why?
Haiti220225530.070 Why?
Opiate Substitution Treatment120124520.070 Why?
HIV Seronegativity120082090.070 Why?
Multivariate Analysis22019120640.070 Why?
Drug Resistance, Multiple120082550.070 Why?
Cycloserine220241180.070 Why?
Cost-Benefit Analysis3202455360.070 Why?
Latvia32012150.070 Why?
HIV Seropositivity120129620.070 Why?
Medical Records Systems, Computerized2200411960.070 Why?
Estonia32012560.070 Why?
Incidence52019215250.060 Why?
Recurrence3201885070.060 Why?
Biomedical Research1202134590.060 Why?
Quinolines120117690.060 Why?
Reverse Transcriptase Polymerase Chain Reaction2202345700.060 Why?
Program Evaluation2201125040.060 Why?
Education120085310.060 Why?
Mutation42023302130.060 Why?
Internationality1201010060.060 Why?
Health Services Needs and Demand1201314040.060 Why?
Kazakhstan12024190.060 Why?
Analysis of Variance1201362140.060 Why?
Genotype22023130360.060 Why?
Risk1201696020.060 Why?
Algorithms22023140720.060 Why?
Buprenorphine120126670.060 Why?
Health Services Accessibility3202055140.060 Why?
Infant52025364610.060 Why?
Substance-Related Disorders2201244210.060 Why?
Infection Control120109840.050 Why?
Medication Systems, Hospital120041540.050 Why?
Motivation1201320200.050 Why?
Reverse Transcription12022480.050 Why?
Age Factors32016183970.050 Why?
Models, Statistical2202050910.050 Why?
Computer Simulation4202062590.050 Why?
Mass Screening1201854540.050 Why?
Delivery of Health Care1202053680.050 Why?
Electrocardiography1201564080.050 Why?
Combined Modality Therapy2201685400.050 Why?
Confidence Intervals2202029210.050 Why?
Models, Genetic1201134500.050 Why?
Aged, 80 and over42021595500.050 Why?
Selection Bias120223590.040 Why?
Risk Factors72016748810.040 Why?
Live Birth120245160.040 Why?
Asthma1201962680.040 Why?
Information Systems120024000.040 Why?
Linguistics120201100.040 Why?
Cross Infection1200814270.040 Why?
Diabetes Mellitus1201858870.040 Why?
Health Policy1201126980.040 Why?
Nasopharynx120224190.040 Why?
Patient Compliance2201326940.040 Why?
Organizational Case Studies120203010.040 Why?
Nepal120203020.040 Why?
Tuberculin Test120192050.040 Why?
Amikacin12018480.040 Why?
Off-Label Use120201850.040 Why?
Europe2201934300.040 Why?
Methicillin Resistance119991980.040 Why?
Probability1200424760.040 Why?
Statistics, Nonparametric1200428460.040 Why?
ROC Curve2201836200.040 Why?
Immunoglobulin M1202315270.040 Why?
Terminology as Topic1200515400.040 Why?
Decision Making1201139510.040 Why?
Medication Errors120047840.040 Why?
Specimen Handling120227060.040 Why?
Public Health2201126810.040 Why?
Postoperative Complications12020158310.040 Why?
Saliva120228520.040 Why?
Carbapenems120181250.040 Why?
Opioid-Related Disorders1201221880.040 Why?
User-Computer Interface1200414090.040 Why?
Peripheral Nervous System Diseases120037130.030 Why?
Social Responsibility120203820.030 Why?
Hospitals, General120218040.030 Why?
Age Distribution2200328690.030 Why?
Skin Tests120196300.030 Why?
HIV1202415880.030 Why?
Single-Blind Method1202015870.030 Why?
Analgesics, Opioid1201238370.030 Why?
Blood Pressure Monitoring, Ambulatory120182530.030 Why?
Urinalysis120183690.030 Why?
Spirometry120199290.030 Why?
Health Status2202040870.030 Why?
Infant, Newborn32024263890.030 Why?
Sequence Analysis, DNA2201647800.030 Why?
Macrolides120162040.030 Why?
Sensitivity and Specificity22023146520.030 Why?
Sex Factors22020106190.030 Why?
Area Under Curve1201816380.030 Why?
Logistic Models22019132780.030 Why?
Survival Analysis22018101000.030 Why?
Biological Assay120166260.030 Why?
Ciprofloxacin120153140.030 Why?
Anti-HIV Agents1200945620.030 Why?
Communicable Disease Control220118570.030 Why?
Medication Adherence1202421900.020 Why?
Georgia (Republic)12011390.020 Why?
Predictive Value of Tests32012154160.020 Why?
Rural Population1202223210.020 Why?
Antibodies, Viral1202332120.020 Why?
HIV-11200969480.020 Why?
Body Mass Index22024130500.020 Why?
Policy120155120.020 Why?
Drug Therapy120145040.020 Why?
Immunoglobulin G1202345590.020 Why?
Pilot Projects2201687280.020 Why?
Odds Ratio2201296610.020 Why?
Empirical Research120101190.020 Why?
United States Food and Drug Administration1201816730.020 Why?
Vulnerable Populations120157180.020 Why?
Registries1200583510.020 Why?
Disease Management2201525330.020 Why?
Mental Disorders1200868690.020 Why?
Phylogeny1201628400.020 Why?
Pregnancy22024302370.020 Why?
Patient-Centered Care1201814450.020 Why?
Drug Evaluation, Preclinical1201213310.020 Why?
Feasibility Studies1201853060.020 Why?
Animals420121689300.020 Why?
Secondary Prevention1201214690.020 Why?
Microscopy120119020.020 Why?
Case-Control Studies12004222480.020 Why?
Massachusetts1199888910.020 Why?
Risk Assessment22004242950.020 Why?
Guidelines as Topic1201113940.010 Why?
Prothionamide1200430.010 Why?
Aminosalicylic Acid12004200.010 Why?
Streptomycin12004690.010 Why?
Korea12004970.010 Why?
Retreatment120065980.010 Why?
Models, Theoretical1201635610.010 Why?
Patient Selection1201642520.010 Why?
Gene Expression1201675850.010 Why?
Alcohol Drinking1201640450.010 Why?
Self Administration120043860.010 Why?
Disease Progression12019136400.010 Why?
Pandemics1202287350.010 Why?
Information Management120021000.010 Why?
Longitudinal Studies12016147620.010 Why?
Chronic Disease1201593570.010 Why?
Research1200819770.010 Why?
Quality of Life12020134760.010 Why?
Prognosis12018299480.010 Why?
Sex Distribution1200322740.010 Why?
Electromyography1200313980.010 Why?
Cross-Sectional Studies12019263100.010 Why?
Health Planning119982330.010 Why?
Morals119982880.010 Why?
Nurses1200425030.010 Why?
United States12018729510.010 Why?
Internet1200231130.010 Why?
Severity of Illness Index12003159080.000 Why?
Mitnick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (300)
Explore
_
Co-Authors (49)
Explore
_
Similar People (58)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.